Dr. Sean Duane Kalloo, MBA, MD

Dr. Kalloo practices at Columbia University Irving Medical Center in New York, New York.

Dr. Kalloo's NPI, 1912160250, was assigned on July 8, 2008. Dr. Kalloo graduated from State University of New York Downstate Medical Center College of Medicine in 2006. Dr. Kalloo holds New York license 252732.

Dr. Kalloo's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Kalloo's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Kalloo is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Kalloo to 1 more hospital, 5 medical groups and 2 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalloo practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kalloo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kalloo is licensed in New York.

CMS data shows 346 Medicare services from Dr. Kalloo across 10 procedure codes in 2024, for 114 Medicare patients. Medicare paid $38,414 for them.

CMS counts 114 Medicare patients who saw Dr. Kalloo in 2024. The largest group is under 65, with 48 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 8.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalloo's median patient age at 65, with 39% women.

In 2024, Dr. Kalloo wrote 69 Medicare Part D claims. 99% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $2,171 in total drug cost. In 2023, CMS named 52 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kalloo for performance year 2024, reported through an alternative payment model (APM). Dr. Kalloo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Kalloo, published from 2013 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Renal Dialysis, Arteriovenous Shunt, Surgical and Kidney Neoplasms. Dr. Kalloo has published most often in Clin J Am Soc Nephrol. Dr. Kalloo's most frequent co-authors are James M. McKiernan, MD, Guarionex Joel Decastro, MD and Roy Oomen Mathew, MD.

CMS Open Payments shows 364 general payments to Dr. Kalloo from 21 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 37% of the total. Fresenius USA Marketing, Inc. paid the most, $77,376.

Dr. Kalloo graduated from State University of New York Downstate Medical Center College of Medicine in 2006.

Dr. Kalloo is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.